To be Functional, or not to be Low in Cholesterol, that is the Clinical Concern when Evaluating Anti-Atherosclerotic Actions of High-Density Lipoproteins.
作者信息
Yoshida Hiroshi
机构信息
Department of Laboratory Medicine, The Jikei University Kashiwa Hospital.
出版信息
J Atheroscler Thromb. 2021 Jul 1;28(7):694-695. doi: 10.5551/jat.ED173. Epub 2021 May 22.
Abstract
摘要
相似文献
1
To be Functional, or not to be Low in Cholesterol, that is the Clinical Concern when Evaluating Anti-Atherosclerotic Actions of High-Density Lipoproteins.具备功能，还是胆固醇水平低，这是评估高密度脂蛋白抗动脉粥样硬化作用时的临床关注点。
J Atheroscler Thromb. 2021 Jul 1;28(7):694-695. doi: 10.5551/jat.ED173. Epub 2021 May 22.
2
The dual nature of HDL: Anti-Inflammatory and pro-Inflammatory.高密度脂蛋白的双重性质：抗炎和促炎。
Biofactors. 2015 May 6;41(3):153-9. doi: 10.1002/biof.1205. Epub 2015 Jun 13.
3
High density lipoprotein, apolipoprotein A-I, and coronary artery disease.高密度脂蛋白、载脂蛋白A-I与冠状动脉疾病。
Mol Cell Biochem. 2000 Jun;209(1-2):131-44. doi: 10.1023/a:1007111830472.
4
Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.动脉粥样硬化患者的 ABCA1 胆固醇外排功能受损，且髓过氧化物酶增强了高密度脂蛋白的氧化。
Circ Res. 2014 May 23;114(11):1733-42. doi: 10.1161/CIRCRESAHA.114.303454. Epub 2014 Mar 19.
5
Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk.载脂蛋白 E 和 CIII 相互作用调节 HDL 代谢和冠心病风险。
JCI Insight. 2018 Feb 22;3(4). doi: 10.1172/jci.insight.98045.
6
Ecto-F1-ATPase/P2Y pathways in metabolic and vascular functions of high density lipoproteins.高密度脂蛋白代谢和血管功能中的胞外F1-ATP酶/P2Y途径
Atherosclerosis. 2015 Jan;238(1):89-100. doi: 10.1016/j.atherosclerosis.2014.11.017. Epub 2014 Nov 20.
7
Antiinflammatory actions of HDL: a new insight.高密度脂蛋白的抗炎作用：新见解
Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1890-1. doi: 10.1161/ATVBAHA.108.173575.
8
Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein.髓过氧化物酶、炎症与功能失调的高密度脂蛋白。
J Clin Lipidol. 2010 Sep-Oct;4(5):382-8. doi: 10.1016/j.jacl.2010.08.007.
9
Trimerized apolipoprotein A-I (TripA) forms lipoproteins, activates lecithin: cholesterol acyltransferase, elicits lipid efflux, and is transported through aortic endothelial cells.三聚体载脂蛋白A-I（TripA）形成脂蛋白，激活卵磷脂：胆固醇酰基转移酶，引发脂质流出，并通过主动脉内皮细胞运输。
Biochim Biophys Acta. 2011 Dec;1811(12):1115-23. doi: 10.1016/j.bbalip.2011.09.001. Epub 2011 Sep 10.
10
Health benefits of high-density lipoproteins in preventing cardiovascular diseases.高密度脂蛋白在预防心血管疾病方面的健康益处。
J Clin Lipidol. 2012 Nov-Dec;6(6):524-33. doi: 10.1016/j.jacl.2012.04.004. Epub 2012 Apr 13.
本文引用的文献
1
Development and Clinical Application of an Enzyme-Linked Immunosorbent Assay for Oxidized High-Density Lipoprotein.氧化型高密度脂蛋白酶联免疫吸附测定法的研发与临床应用
J Atheroscler Thromb. 2021 Jul 1;28(7):703-715. doi: 10.5551/jat.56887. Epub 2020 Oct 17.
2
High-Density Lipoprotein Cholesterol Efflux Capacity as a Novel Prognostic Surrogate for Coronary Artery Disease.高密度脂蛋白胆固醇外排能力作为冠状动脉疾病的新型预后替代指标。
J Atheroscler Thromb. 2021 Jul 1;28(7):696-702. doi: 10.5551/jat.59279. Epub 2020 Sep 8.
3
Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice.氧化磷脂在高胆固醇血症小鼠中具有促炎和动脉粥样硬化作用。
Nature. 2018 Jun;558(7709):301-306. doi: 10.1038/s41586-018-0198-8. Epub 2018 Jun 6.
4
Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies.极高的高密度脂蛋白胆固醇水平与男性和女性的高死亡率呈矛盾关系：两项前瞻性队列研究。
Eur Heart J. 2017 Aug 21;38(32):2478-2486. doi: 10.1093/eurheartj/ehx163.
5
High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: The CANHEART Study.高密度脂蛋白胆固醇与无既往心血管疾病个体的特定病因死亡率：CANHEART 研究。
J Am Coll Cardiol. 2016 Nov 8;68(19):2073-2083. doi: 10.1016/j.jacc.2016.08.038.
6
Further evidence that high-density lipoprotein is a chameleon-like lipoprotein.进一步证明高密度脂蛋白是一种类似变色龙的脂蛋白。
Eur Heart J. 2015 Nov 14;36(43):3017-9. doi: 10.1093/eurheartj/ehv465. Epub 2015 Sep 15.
7
Dysfunctional HDL and atherosclerotic cardiovascular disease.功能失调的高密度脂蛋白与动脉粥样硬化性心血管疾病。
Nat Rev Cardiol. 2016 Jan;13(1):48-60. doi: 10.1038/nrcardio.2015.124. Epub 2015 Sep 1.
8
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study.高密度脂蛋白胆固醇外排能力与冠心病事件发生的相关性：一项前瞻性病例对照研究。
Lancet Diabetes Endocrinol. 2015 Jul;3(7):507-13. doi: 10.1016/S2213-8587(15)00126-6. Epub 2015 May 27.
9
HDL cholesterol efflux capacity and incident cardiovascular events.高密度脂蛋白胆固醇流出能力与心血管事件的发生
N Engl J Med. 2014 Dec 18;371(25):2383-93. doi: 10.1056/NEJMoa1409065. Epub 2014 Nov 18.
10
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.胆固醇外排能力、高密度脂蛋白功能与动脉粥样硬化。
N Engl J Med. 2011 Jan 13;364(2):127-35. doi: 10.1056/NEJMoa1001689.
Zotero 插件